Under the partnership, M42 will support Botswana’s efforts to transform its healthcare system through digital health, genomics, precision medicine and workforce development.
Dr Tapela holds a Doctor of Medicine (MD) degree and a Master of Public Health (MPH) degree from Harvard University.
Following completion of the transaction, the business will operate under the new name Medswana Laborex and become part of CFAO Healthcare’s pan-African network.